Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gruden Eva |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Danner, L; Pammer, A; Kienzl, M; Ristic, D; Kaspret, D; Doyle, A; Schicho, R; Gruden, E
Cannabinoid receptor 2 is immunoprotective in models of
allergic diseases via differentiation of T regulatory cells
28th Meeting of the Austrian Pharmacological Society; SEP 23-25, 2024; Innsbruck, AUSTRIA. 2024.
[Poster]
Gruden, E; Danner, L; Petracco, G; Kienzl, M; Ristic, D; Oberdorfer, G; Reichmann, F; Schicho, R
Investigating IL-37 as a potential therapeutic option in inflammatory GI disorders
28th Meeting of the Austrian Pharmacological Society; SEP 23-25, 2024; Innsbruck, AUSTRIA. 2024.
[Poster]
Petracco, G; Tatzl, E; Faimann, I; Kienzl, M; Gruden, E; Schicho, R; Reichmann, F
Sex-based differences in a mouse model of experimental colitis housed in environmental enrichment
Posterbook of the 2nd INGE St. Day. 2024; -Second public INGE St. Day; DEC 3, 2024; Graz, AUSTRIA.
[Poster]
Petracco, G; Tatzl, E; Faimann, I; Kienzl, M; Gruden, E; Schicho, R; Reichmann, F
SEX-BASED DIFFERENCES IN A MOUSE MODEL OF EXPERIMENTAL
COLITIS HOUSED IN ENVIRONMENTAL ENRICHMENT
7th BraYn - Brainstorming Research Assembly for Young Neuroscientists; OCT 9-11, 2024; Verona, ITALY. 2024.
[Poster]
Gruden, E
Vloga eozinofilcev v zdravju in bolezni.
Golniški simpozij z mednarodno udeležbo 2023; OCT 5-7, 2023; Bled, Slovenia. 2023.
[Oral Communication]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristić, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R
Multicolor flow cytometric determination of immune-cell composition and activation in eosinophilic esophagitis
27th Scientific Symposium of the Austrian Pharmacological Society; SEP 29-30, 2023; Vienna. 2023.
[Poster]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristić, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R.
Analysis of Immune cell Composition and Activation in Eosinophilic Esophagitis
ÖGAI 2023 Annual Meeting; SEP 14-16, 2023; Linz. 2023.
[Poster]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristic, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho, R
Multicolor Flow Cytometric Determination of Immune Cell Composition and Activation in Eosinophilic Esophagitis
12th Biennial Symposium of the International Eosinophil Society; JUL 11-15, 2023; Hamilton, CANADA. 2023.
[Poster]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Doyle, A; Baumann-Durschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R
Monoacylglycerol Lipase Inhibition In Esophageal Epithelial Cells In Pathogenesis of Eosinophilic Esophagitis
12th Biennial Symposium of the International Eosinophil Society; JUL 11-15, 2023; Hamilton Canada. 2023.
[Poster]
Kienzl, M; Herceg, K; Gruden, E; Ristic, D; Sarsembayeva, A; Maitz, K; Kargl, J; Schicho, R
Investigating the impact of eosinophils on lung cancer progression
ÖGAI 2023 Annual Meeting; SEP 14-16, 2023; Linz, AUSTRIA. 2023.
[Poster]
Ristic, D; Kienzl, M; Gruden, E; Sarsembayeva, A; Herceg, K; Kargl, J; Schicho, R
G Protein-Coupled Receptor 55 in Pancreatic Cancer: An Immunomodulatory Role.
27th Scientific Symposium of the Austrian Pharmacological Society; SEP 29-30, 2023; Vienna. 2023.
[Poster]
Ristic, D; Kienzl, M; Sarsembayeva, A; Herceg, K; Kargl, J; Schicho, R
G Protein-Coupled Receptor 55 in Pancreatic Cancer: An Immunomodulatory Role.
Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI); SEP 14-16, 2023; Linz, Austria. 2023.
[Poster]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Baumann-Durchschein, F; Schlager, H; Schicho, R
The implications of monoacylglycerol lipase inhibition in esophageal epithelial cells for the pathogenesis of eosinophilic esophagitis
; SEP 23-24; Graz, Austria. 2022.
[Oral Communication]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Schicho, R
The role of the Cannabinoid receptor 2 (CB2) in T regulatory cell differentiation and function.
EUR J IMMUNOL. 2022; 52: 264-264.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Kienzl, M; Gruden, E; Sarsembayeva, A; Maitz, K; Ristic, D; Valadez-Cosmes, P; Kargl, J; Schicho, R
CRTH2 as a pro-tumorigenic driver in the tumor microenvironment of experimental models of colon cancer
EUR J IMMUNOL. 2022; 52: 281-281.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Kienzl, M; Sarsembayeva, A; Gruden, E; Ristic, D; Maitz, K; Hasenoehrl, C; Sturm, EM; Kargl, J; Schicho, R
Type 1 Activated eosinophils contribute to natural killer cell recruitment and the control of tumor growth in colorectal cancer
14th ÖGMBT Annual Meeting; SEP 19-22, 2022; Vienna. 2022.
[Poster]
Ristic, D; Kienzl, M; Sarsembayeva, A; Gruden, E; Kargl, J; Schicho, R
Pro-tumorigenic role of GPR55 in the immune microenvironment of pancreatic cancer
EUR J IMMUNOL. 2022; 52: 291-291.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Ristic, D; Sarsembayeva, A; Kienzl, M; Gruden, E; Maitz, K; Teppan, J; Raftopoulou, S; Kindler, O; Santiso Sánchez, A; Kargl, J; Strobl, H; Schicho, R;
Role of GPR55 in the tumor microenvironment of pancreatic cancer.
DocDay Medical University of Graz; FEB 10, 2022; Graz, Austria. 2022.
[Poster]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Brcic, L; Kargl, J; Schicho, R
The cannabinoid receptor 2 and its role in tumor progression in non-small cell lung cancer
25th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; Sep 23-24, 2022; Graz, Austria. 2022.
[Oral Communication]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Kargl, J; Schicho, R
Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of T and NK cells
Abstract Book. 2022; -14th ÖGMBT Annual Meeting 2022, 'Life Sciences-now more than ever'; Sep 19-22, 2022; Viennca, Austria.
[Oral Communication]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Kargl, J; Schicho, R
Cannabinoid receptor 2 creates a suppressive tumor immune microenvironment in a mouse model of lung cancer and predicts responsiveness to anti-PD-1 antibody treatment
EUR J IMMUNOL. 2022; 52: 78-79.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Oral Communication]
Web of Science
FullText
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Maitz, K; Hasenoehrl, C; Taschler, U; Valadez-Cosmes, P; Kindler, O; Bärnthaler, T; Brcic, L; Kargl, J; Schicho, R
Cannabinoid receptor 2 expression in cells of the tumor microenvironment determines tumor burden of non-small cell lung cancer
Doctoral day 2022 at the Medical University of Graz; Feb 10, 2022; Graz, Austria. 2022.
[Poster]
Sgrignani, G; Iozzo, M; Di Leonardo, L; Gruden, E; Kienzl, M; Ippolito, L; Pardella, E; Parri, M; Morandi, A; Comito, G; Schicho, R; Giannoni, E; Chiarugi, P
Endocannabinoid system as a regulator of tumor-stroma interplay in a prostate cancer cell model
26th Scientific Symposium of APHAR; SEP 23-24; Graz, Austria. 2022.
[Oral Communication]
Knuplez,E; Curcic, S; Sturm, E; Heinemann, A; Marsche, G.
In vitro and in vivo inhibiton of eosinophil activation by lysophosphatidylcholine and synthetic alkyl-lysophosphatidylcholine
11th Biennial Symposium of the International Eosinophil Society; JUL 9-13; Portland, USA. 2019.
[Poster]
Trakaki, A; Sturm, GJ; Pregartner, G; Scharnagl, H; Eichmann, TO; Trieb, M; Knuplez, E; Holzer, M; Stadler, JT; Heinemann, A; Sturm, EM; Marsche, G
Role of high-density lipoprotein composition and function in allergy
DK-MOLIN Annual Retreat; APR 11-13; Schloss Seggau, Leibnitz, AUSTRIA. 2019.
[Oral Communication]
Knuplez, E; Curcic, S; Cvirn, G; Marsche, G
Role of apolipoprotein C-III on platelet activation
Doctoral Day at the Medical University of Graz; NOV 28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil
over-activation
“Cancer, Inflammation, Immunity” Retreat
Joint DK retreat MCBO/MOLIN/IAI; JAN 13-17, 2018; Obergurgl, AUSTRIA. 2018.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
DK Molin Annual Retreat 2018; APR 11-13, 2018; Schloss Seggau, Austria. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
24th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 27-28, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G
Lysophosphatidylcholine and its synthetic analogue miltefosine potently suppress eosinophil over-activation
WISC 2018- Personalized medicine in allergy: Biologics & Immunotherapy; DEC 05-09, 2018; Florence, ITALY. 2018.
[Poster]
Knuplez, E; Sturm, EM; Heinemann, A; Marsche, G
Lysophosphatidylcholine and its synthetic analogue Miltefosine potently suppress eosinophil over-activation
59th International Conference on the Bioscience of Lipids: ’Lipid Fluxes and Metabolism – From Fundamental Mechanisms to Human Disease’; SEP 4-7, 2018; Helsinki, FINLAND. 2018.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G
Lysophospholipid-enriched HDL suppresses platelet activation
23rd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G.
Secretory phospholipase A2 modified HDL potently inhibits platelet activation
9th ÖGMBT Annual Meeting; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil
over-activation
Doctoral Day at the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
Lysophosphatidylcholine suppresses eosinophil activation
9th ÖGMBT Annual Meeting & 8th Life Sciences Meeting Innsbruck; SEP 25-26, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The role of lysophosphatidylcholine in eosinophil activation
23nd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Knuplez, E; Curcic, S; Heinemann, A; Marsche, G
The role of (secretory) phospholipases in eosinophil function.
DK Molin Annual Retreat; JAN 30 - FEB 1, 2017; Schloss Seggau, AUSTRIA. 2017.
[Oral Communication]